Recent research demonstrate the promise of RMP1-14, a specifically engineered anti-mouse PD-1 antibody , for improving tumor treatment. Unlike current approaches, RMP1-14 exhibits superior affinity to https://www.targetmol.com/compound/anti_mouse_pd_1_antibody_rmp1_14